Sequana Medical (Belgium) Performance
| SEQUA Stock | 0.70 0.03 4.11% |
The entity has a beta of 1.22, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sequana Medical will likely underperform. At this point, Sequana Medical NV has a negative expected return of -0.0057%. Please make sure to validate Sequana Medical's value at risk and the relationship between the expected short fall and price action indicator , to decide if Sequana Medical NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sequana Medical NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, Sequana Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 11 M | |
| Total Cashflows From Investing Activities | -338 K |
Sequana |
Sequana Medical Relative Risk vs. Return Landscape
If you would invest 93.00 in Sequana Medical NV on September 18, 2024 and sell it today you would lose (23.00) from holding Sequana Medical NV or give up 24.73% of portfolio value over 90 days. Sequana Medical NV is generating negative expected returns and assumes 9.276% volatility on return distribution over the 90 days horizon. Simply put, 82% of stocks are less volatile than Sequana, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sequana Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sequana Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sequana Medical NV, and traders can use it to determine the average amount a Sequana Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -6.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SEQUA |
Estimated Market Risk
| 9.28 actual daily | 82 82% of assets are less volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sequana Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sequana Medical by adding Sequana Medical to a well-diversified portfolio.
Sequana Medical Fundamentals Growth
Sequana Stock prices reflect investors' perceptions of the future prospects and financial health of Sequana Medical, and Sequana Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sequana Stock performance.
| Return On Equity | -2.22 | |||
| Return On Asset | -0.54 | |||
| Current Valuation | 134.46 M | |||
| Shares Outstanding | 23.75 M | |||
| Price To Book | 11.52 X | |||
| Price To Sales | 182.39 X | |||
| Revenue | 370.5 K | |||
| EBITDA | (22.24 M) | |||
| Total Debt | 7.32 M | |||
| Book Value Per Share | 0.55 X | |||
| Cash Flow From Operations | (23.62 M) | |||
| Earnings Per Share | (1.30) X | |||
| Total Asset | 14.71 M | |||
About Sequana Medical Performance
By analyzing Sequana Medical's fundamental ratios, stakeholders can gain valuable insights into Sequana Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sequana Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sequana Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Sequana Medical NV performance evaluation
Checking the ongoing alerts about Sequana Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sequana Medical NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sequana Medical NV generated a negative expected return over the last 90 days | |
| Sequana Medical NV has high historical volatility and very poor performance | |
| Sequana Medical NV has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 370.5 K. Net Loss for the year was (23.62 M) with profit before overhead, payroll, taxes, and interest of 718 K. | |
| Sequana Medical generates negative cash flow from operations | |
| About 14.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Sequana Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sequana Medical's stock is overvalued or undervalued compared to its peers.
- Examining Sequana Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sequana Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sequana Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sequana Medical's stock. These opinions can provide insight into Sequana Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sequana Stock analysis
When running Sequana Medical's price analysis, check to measure Sequana Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequana Medical is operating at the current time. Most of Sequana Medical's value examination focuses on studying past and present price action to predict the probability of Sequana Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequana Medical's price. Additionally, you may evaluate how the addition of Sequana Medical to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |